Alto Neuroscience (ANRO) Profit After Tax (2023 - 2026)

Alto Neuroscience has disclosed Profit After Tax across 4 years of filings, most recently posting -$26.2 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$26.2 million, down 72.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$74.3 million (down 17.6% YoY), and the FY2025 annual result was -$63.2 million, down 2.94% from the prior year.
• Profit After Tax came in at -$26.2 million for Q1 2026 at Alto Neuroscience, down from -$16.2 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$7.3 million in Q1 2023 to a low of -$26.2 million in Q1 2026.
• The 4-year median for Profit After Tax is -$15.2 million (2025), against an average of -$14.4 million.
• Across the five-year window, Profit After Tax sank 85.04% in 2024 and gained 15.5% in 2025, its largest moves.
• Alto Neuroscience's Profit After Tax stood at -$11.2 million in 2023, then plunged by 35.52% to -$15.2 million in 2024, then dropped by 6.45% to -$16.2 million in 2025, then sank by 62.14% to -$26.2 million in 2026.
• The last three Profit After Tax figures came in at -$26.2 million (Q1 2026), -$16.2 million (Q4 2025), and -$14.2 million (Q3 2025), per Business Quant data.